| Product Code: ETC6186946 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Opiods Drug Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Opiods Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Opiods Drug Market - Industry Life Cycle |
3.4 Australia Opiods Drug Market - Porter's Five Forces |
3.5 Australia Opiods Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Opiods Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Opiods Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Opiods Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Australia |
4.2.2 Growing geriatric population in Australia |
4.2.3 Rising awareness about the availability and benefits of opioid drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies related to opioid prescribing and dispensing |
4.3.2 Concerns about opioid abuse and addiction in Australia |
5 Australia Opiods Drug Market Trends |
6 Australia Opiods Drug Market, By Types |
6.1 Australia Opiods Drug Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Opiods Drug Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Opiods Drug Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.4 Australia Opiods Drug Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.5 Australia Opiods Drug Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.1.6 Australia Opiods Drug Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.7 Australia Opiods Drug Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.1.8 Australia Opiods Drug Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.2 Australia Opiods Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Opiods Drug Market Revenues & Volume, By Pain Relief, 2021- 2031F |
6.2.3 Australia Opiods Drug Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.4 Australia Opiods Drug Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.2.5 Australia Opiods Drug Market Revenues & Volume, By Diarrhea Suppression, 2021- 2031F |
6.2.6 Australia Opiods Drug Market Revenues & Volume, By Deaddiction, 2021- 2031F |
6.3 Australia Opiods Drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Opiods Drug Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Australia Opiods Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Australia Opiods Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 Australia Opiods Drug Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.6 Australia Opiods Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Opiods Drug Market Import-Export Trade Statistics |
7.1 Australia Opiods Drug Market Export to Major Countries |
7.2 Australia Opiods Drug Market Imports from Major Countries |
8 Australia Opiods Drug Market Key Performance Indicators |
8.1 Prescription rates of opioid drugs for chronic pain management |
8.2 Number of opioid-related hospital admissions |
8.3 Percentage of healthcare professionals trained in safe opioid prescribing practices. |
9 Australia Opiods Drug Market - Opportunity Assessment |
9.1 Australia Opiods Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Opiods Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Opiods Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Opiods Drug Market - Competitive Landscape |
10.1 Australia Opiods Drug Market Revenue Share, By Companies, 2024 |
10.2 Australia Opiods Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here